Please login to the form below

Not currently logged in

Novo's Q2 profit up 17 per cent

Novo Nordisk has reported a net profit of 4.13bn DKK in its financial results for the second quarter of 2011, with strong sales of diabetes drug Victoza driving the company's performance

Novo Nordisk has reported a net profit of 4.13bn DKK in its financial results for the second quarter of 2011, an increase of 17 per cent from figures recorded over the same period in 2010.

The Denmark-based company managed to increase sales by 4 per cent, making 16.00bn DKK for the quarter, with its diabetes products comprising the bulk of this figure.

Type 2 diabetes drug, Victoza (liraglutide) was an especially strong performer for the company, making 1.25bn DKK with sales increasing by 322 per cent. The drug was approved in the EU in July 2009 and in the US in January 2010.

This helped counter declining sales in human insulins, with revenue for related products down by 15 per cent.

Overall, diabetes products made 12.04bn DKK during the second quarter, an increase of 5 per cent.

As well as increased total sales, Novo decreased its financial expenses significantly (by 71 per cent) and reduced R&D costs by over 100m DKK.

Half-year figures were similarly positive, with sales up by 9 per cent to 31.69bn DKK and net profit rising to 8.21bn DKK.

Lars Rebien Sørensen, president and CEO, Novo, said he was "satisified" with the company's performance, and announced the financial outlook for 2011 would adjusted upwards.

4th August 2011


Featured jobs

Subscribe to our email news alerts


Add my company

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked